advertisement

WGA Rescources

Wu RY 1

Showing records 1 to 1 | Display all abstracts from Wu RY

106854 Safety profile of 0.0015% tafluprost eye drops in China: a post-marketing observational study
Chen XL; Fu YJ; Qu B; Wang YW; Tang X; Wang YH; Zhou GY; Lin MK; Shen JY; Yao J; Li SY; Wu MQ; Peng HZ; Lai MY; Wu RY; Zhang YN; Li Y; Wu XJ; Zhang MC; Guo SP; Sun XH
International Journal of Ophthalmology 2023; 16: 108-114

Issue 23-3

Change Issue


advertisement

Oculus